QBTS vs. RTO, ALLE, FTAI, CART, ULS, MEDP, STN, BILI, WPP, and HQY
Should you be buying D-Wave Quantum stock or one of its competitors? The main competitors of D-Wave Quantum include Rentokil Initial (RTO), Allegion (ALLE), FTAI Aviation (FTAI), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Bilibili (BILI), WPP (WPP), and HealthEquity (HQY). These companies are all part of the "business services" industry.
D-Wave Quantum vs.
Rentokil Initial (NYSE:RTO) and D-Wave Quantum (NYSE:QBTS) are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability, community ranking and earnings.
Rentokil Initial has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, D-Wave Quantum has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.
Rentokil Initial has a net margin of 0.00% compared to D-Wave Quantum's net margin of -783.28%.
9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 42.5% of D-Wave Quantum shares are owned by institutional investors. 7.2% of D-Wave Quantum shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Rentokil Initial has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.
D-Wave Quantum received 26 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 88.57% of users gave D-Wave Quantum an outperform vote while only 35.71% of users gave Rentokil Initial an outperform vote.
D-Wave Quantum has a consensus target price of $8.42, indicating a potential downside of 2.96%. Given D-Wave Quantum's stronger consensus rating and higher probable upside, analysts clearly believe D-Wave Quantum is more favorable than Rentokil Initial.
In the previous week, D-Wave Quantum had 45 more articles in the media than Rentokil Initial. MarketBeat recorded 48 mentions for D-Wave Quantum and 3 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.72 beat D-Wave Quantum's score of 0.57 indicating that Rentokil Initial is being referred to more favorably in the media.
Summary
Rentokil Initial and D-Wave Quantum tied by winning 9 of the 18 factors compared between the two stocks.
Get D-Wave Quantum News Delivered to You Automatically
Sign up to receive the latest news and ratings for QBTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
D-Wave Quantum Competitors List
Related Companies and Tools
This page (NYSE:QBTS) was last updated on 3/24/2025 by MarketBeat.com Staff